UBC Rapid
Bladder Cancer Monitoring
CommercialActive
Key Facts
About IDL Diagnostics
IDL Diagnostics, formerly known as AroCell, is a commercial-stage diagnostics company specializing in cancer monitoring. Its core technology is based on the Thymidine Kinase 1 (TK1) biomarker, offered in formats like the UBC Rapid point-of-care test and the TK 210 ELISA for automated platforms. The company is actively commercializing its products through distributor partnerships in Asia and Europe while engaging in clinical studies to expand the utility of its TK1 assays across various cancer types.
View full company profile